Get the Stockscreener App
111.88
0.40%
0.45
After Hours:
111.88
Repligen Corp stock is traded at $111.88, with a volume of 559.44K.
It is up +0.40% in the last 24 hours and down -14.06% over the past month.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
See More
Previous Close:
$111.43
Open:
$111.54
24h Volume:
559.44K
Relative Volume:
0.69
Market Cap:
$6.29B
Revenue:
$633.51M
Net Income/Loss:
$-8.10M
P/E Ratio:
-360.90
EPS:
-0.31
Net Cash Flow:
$131.26M
1W Performance:
-3.97%
1M Performance:
-14.06%
6M Performance:
-25.16%
1Y Performance:
-32.26%
1-Day Range:
$111.23
$112.98
1-Week Range:
$110.77
$117.72
52-Week Range:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Name
Repligen Corp
Sector
Industry
Phone
(781) 449-9560
Address
41 SEYON STREET, WALTHAM, MA
Compare RGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
111.88 | 6.27B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
471.85 | 168.51B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
192.50 | 55.46B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
84.68 | 42.41B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
284.32 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
240.33 | 17.33B | 2.90B | 467.20M | 306.90M | 6.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-25 | Resumed | Stephens | Overweight |
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-29-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Mar-18-25 | Initiated | Evercore ISI | In-line |
| Feb-10-25 | Initiated | TD Cowen | Buy |
| Dec-17-24 | Initiated | Canaccord Genuity | Hold |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-18-24 | Initiated | Guggenheim | Neutral |
| Dec-04-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Mar-28-23 | Initiated | The Benchmark Company | Buy |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-22 | Initiated | UBS | Buy |
| Oct-14-21 | Initiated | Exane BNP Paribas | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| May-07-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-23-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Nov-01-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-15-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-19 | Reiterated | First Analysis Sec | Outperform |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jul-22-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-17-18 | Upgrade | CL King | Neutral → Buy |
| Nov-12-18 | Downgrade | CL King | Buy → Neutral |
| Sep-26-18 | Initiated | H.C. Wainwright | Neutral |
| Dec-08-17 | Initiated | Citigroup | Buy |
| Dec-05-17 | Initiated | JP Morgan | Overweight |
| Nov-13-17 | Initiated | CL King | Buy |
| Oct-02-17 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Jul-21-17 | Initiated | William Blair | Outperform |
| Feb-13-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Repligen Corp Stock (RGEN) Latest News
Using economic indicators to assess Repligen Corporation potentialEntry Zone Forecast for Momentum Trading - Newser
Can trapped investors hope for a rebound in Repligen CorporationShort Term Opportunity Finder with Tools - Newser
Can machine learning forecast Repligen Corporation recoveryHigh Probability Trade Plan with Indicators - Newser
Will Repligen Corporation rebound enough to break evenFree Pattern Breakout Entry Stock Forecast - Newser
Repligen Corporation stock prediction for this weekFree Secure Return Focused Investment Plan - Newser
Volatility clustering patterns for Repligen CorporationBuy Signal System Based on Price Action - Newser
Will Repligen Corporation benefit from macro trendsFree Daily Stock Market Swing Alerts - Newser
How Repligen Corporation stock performs during market volatilityAutomated AI Forecast with Trading Alerts - Newser
Exit strategy if you’re trapped in Repligen CorporationSafe Entry Zone Based on Chart Analysis - Newser
Sector ETF performance correlation with Repligen CorporationPattern Recognition Tool for ROI Investors - Newser
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight - GuruFocus
Live market analysis of Repligen CorporationDaily Entry Opportunity Forecasting Tool - Newser
REPLIGEN CORP SEC 10-Q Report - TradingView
Pattern recognition hints at Repligen Corporation upsideFree Fast Gaining Stock Screener Report - Newser
Long term hold vs stop loss in Repligen CorporationFree Expert Verified Stock Trade Ideas - Newser
Repligen (NASDAQ:RGEN) Investors Are Sitting on a Loss of 53% If They Invested Three Years Ago - 富途牛牛
Visual analytics tools that track Repligen Corporation performanceInvestment Roadmap for High Potential Stocks - Newser
Fund Update: GENEVA CAPITAL MANAGEMENT LLC added 343,991 shares of REPLIGEN ($RGEN) to their portfolio - Quiver Quantitative
Why Repligen Corporation stock attracts strong analyst attentionSmart Chart Forecasting with AI Algorithms - Newser
What Fibonacci levels say about Repligen Corporation reboundFree Access to Smart Investment Tips - Newser
Geneva Capital Management LLC Buys 7,958 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Why is Repligen Corporation stock attracting strong analyst attentionUnlock exclusive trading strategies for gains - Jammu Links News
Can Repligen Corporation recover in the next quarterBuy Signal Forecast With Short-Term Data - Newser
William Blair Analysts Raise Earnings Estimates for Repligen - Defense World
Pacer Advisors Inc. Cuts Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by Nicolet Advisory Services LLC - Defense World
Blueshift Asset Management LLC Takes $458,000 Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
TD Asset Management Inc Has $6.51 Million Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Evaluating Repligen Corporation with trendline analysisWatchlist Generator With Real-Time Entry - Newser
Q3 Earnings Forecast for Repligen Issued By Leerink Partnrs - Defense World
XTX Topco Ltd Buys 3,295 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Wealthquest Corp Takes Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Royal Bank Of Canada Raises Repligen (NASDAQ:RGEN) Price Target to $204.00 - Defense World
Harvest Fund Management Co. Ltd Invests $132,000 in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Stock Outlook: Risk Skewed To The Downside Through 2026 - Benzinga
Repligen (RGEN) Partners with Novasign to Enhance Filtration Systems - GuruFocus
Repligen Corporation (NASDAQ:RGEN) Q2 2025 Earnings Call Transcript - Insider Monkey
Repligen partners with Novasign to enhance bioprocessing systems - Investing.com
Repligen partners with Novasign to enhance bioprocessing systems By Investing.com - Investing.com Canada
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization - Yahoo Finance
Repligen Corporation (NASDAQ:RGEN) Shares Sold by Norden Group LLC - Defense World
Repligen Corporation (NASDAQ:RGEN) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Repligen Corporation stock outlook for YEARFast Movement Forecast for Trading Success - Newser
Repligen Corporation Reports Strong Q2 2025 Growth - The Globe and Mail
What candlestick patterns are forming on Repligen CorporationFree Real Time Stock Movement Analysis - Newser
Repligen Corp Reports Strong Revenue Growth Amid Market Challenges - AInvest
Repligen stock rating reiterated at Overweight by KeyBanc on bioprocessing growth - Investing.com Canada
Thornburg Investment Management Inc. Sells 1,646 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
North Star Asset Management Inc. Sells 334 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corp (RGEN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Investing.com Canada
Repligen Corp Stock (RGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.62%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):